Antares Pharma, Inc. (NASDAQ:ATRS)

CAPS Rating: 4 out of 5

The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems.

Recs

1
Player Avatar EclecticRecluse (78.41) Submitted: 10/26/2010 3:40:30 PM : Underperform Start Price: $1.40 ATRS Score: -62.10

Extremely High Price for Sales

Featured Broker Partners


Advertisement